6AIY image
Deposition Date 2018-08-25
Release Date 2018-10-17
Last Version Date 2024-05-29
Entry Detail
PDB ID:
6AIY
Title:
Crystal structure of DXO (E234A mutant) in complex with adenosine 3', 5' bisphosphate and two magnesium ions
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Decapping and exoribonuclease protein
Gene (Uniprot):Dxo
Mutations:E234A
Chain IDs:A
Chain Length:378
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Molecular mechanism for the inhibition of DXO by adenosine 3',5'-bisphosphate.
Biochem. Biophys. Res. Commun. 504 89 95 (2018)
PMID: 30180947 DOI: 10.1016/j.bbrc.2018.08.135

Abstact

The decapping exoribonuclease DXO functions in pre-mRNA capping quality control, and shows multiple biochemical activities such as decapping, deNADding, pyrophosphohydrolase, and 5'-3' exoribonuclease activities. Previous studies revealed the molecular mechanisms of DXO based on the structures in complexes with a product, substrate mimic, cap analogue, and 3'-NADP+. Despite several reports on the substrate-specific reaction mechanism, the inhibitory mechanism of DXO remains elusive. Here, we demonstrate that adenosine 3', 5'-bisphosphate (pAp), a known inhibitor of the 5'-3' exoribonuclease Xrn1, inhibits the nuclease activity of DXO based on the results of structural and biochemical experiments. We determined the crystal structure of the DXO-pAp-Mg2+ complex at 1.8 Å resolution. In comparison with the DXO-RNA product complex, the position of pAp is well superimposed with the first nucleotide of the product RNA in the vicinity of two magnesium ions. Furthermore, biochemical assays showed that the inhibition by pAp is comparable between Xrn1 and DXO. Collectively, these structural and biochemical studies reveal that pAp inhibits the activities of DXO by occupying the active site to act as a competitive inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures